# Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel

> **NCT00447499** · PHASE3 · COMPLETED · sponsor: **Ipsen** · enrollment: 59 (actual)

## Conditions studied

- Acromegaly

## Interventions

- **DRUG:** Somatuline Autogel (lanreotide acetate)
- **BEHAVIORAL:** Home administration

## Key facts

- **NCT ID:** NCT00447499
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2020-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00447499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00447499, "Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00447499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*